Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases
Even the experts were startled by the remarkable success of the two first-of-their-kind messenger RNA vaccines developed by Moderna and Pfizer/BioNTech against COVID-19.